Clinical Trials Logo

Filter by:
NCT ID: NCT03779451 Recruiting - Placenta Previa Clinical Trials

Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Purpose to evaluate the effects of Vaginal Progesterone versus 17-Alpha-Hydroxyprogesterone Caproate for prevention of Emergent Cesarean Delivery in Asymptomatic Pregnant Women with Placenta Previa

NCT ID: NCT03779438 Recruiting - Placenta Previa Clinical Trials

17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Purpose to evaluate the effects of intramuscular 17-Alpha-Hydroxyprogesterone Caproate (17-OHPC) for prevention of Emergent Cesarean Delivery in symptomatic Pregnant Women with Placenta Previa

NCT ID: NCT03778944 Recruiting - Anesthesia Clinical Trials

Enhancing Renal Graft Function During Donor Anesthesia

Start date: December 20, 2018
Phase: N/A
Study type: Interventional

Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the transplanted kidney. The aim of this study is to assess & compare the effectiveness of 3 different modalities in this respect: Mannitol, Dopamine and adequate hydration.

NCT ID: NCT03778463 Recruiting - Clinical trials for Arthroplasty, Replacement, Knee

Synovectomy in Primary Total Knee Arthrplasty

Start date: December 2018
Phase: N/A
Study type: Interventional

The aim of total knee arthroplasty is to achieve best patient functional outcomes, improve patient pain score and satisfaction. Synovial proliferation is a common finding in arthritic knees. Surgeons can't decide if synovectomy is a crucial step in the operation. Studies didn't prove the clear benefits of synovectomy. We are aiming to perform a randomized clinical trial trying to reach the best evidence in that matter.

NCT ID: NCT03777878 Recruiting - Clinical trials for Cesarean Section Complications

Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Purpose to evaluates the effects of oxytocin infusion with or without intravenous tranexamic acid (TA) in comparison with Carbetocin for prevention of postpartum hemorrhage at a cesarean section with one or more risk factor for postpartum hemorrhage.

NCT ID: NCT03777696 Recruiting - Clinical trials for Cesarean Section Complications

Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Purpose to evaluate the effects of buccal misoprostol with or without intravenous tranexamic acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women undergoing emergent cesarean section

NCT ID: NCT03777566 Recruiting - Cavity Clinical Trials

Uterine Cavity Volume Measuring With Sonohysterography: A New Objective Method

Start date: February 10, 2019
Phase:
Study type: Observational [Patient Registry]

Measuring of uterine cavity volume using sonohysterography will be done in two groups of patients, Group A included 35 patients for home hysterectomy were indicated and group B includes 150 infertile patients in the childbearing age.

NCT ID: NCT03774706 Recruiting - Clinical trials for Cesarean Section Complications

Sublingual Misoprostol With or Without Intravenous Tranexamic Acid During Hemorrhagic Cesarean Section

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Purpose to evaluates the effects of sublingual misoprostol with or without intravenous tranexamic acid (TA) on reducing post-partum hemorrhage during and after hemorrhagic cesarean section.

NCT ID: NCT03774680 Recruiting - Colon Cancer Clinical Trials

Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer

Start date: February 1, 2020
Phase: Phase 1
Study type: Interventional

Due to the great toxicity of chemotherapeutic drugs to both the healthy and cancerous area, the efficient targeting could be of great benefit for a patient with advanced or metastatic tumors. Colorectal cells carry somatostatin receptors which make them a promising target for antitumor therapy since this would reduce side effects and increase drug delivery efficacy to the target site.

NCT ID: NCT03774524 Recruiting - Clinical trials for Cesarean Section Complications

Sublingual Misoprostol and Tranexamic Acid in Pregnant Women With Twin Pregnancy Undergoing Cesarean Section

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Purpose to evaluate the effects of sublingual misoprostol with or without intravenous tranexamic acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women with twin pregnancy undergoing an elective cesarean section.